LJAC
FTXH icon

L.J. Altfest & Co’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

L.J. Altfest & Co’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,444
Closed -$251K – 267
2022
Q1 		$251K Sell
9,444
-15,123
-62% -$391K 0.04% 226
2021
Q4 		$665K Sell
24,567
-11,233
-31% -$295K 0.13% 121
2021
Q3 		$923K Sell
35,800
-153,710
-81% -$4.04M 0.19% 87
2021
Q2 		$4.91M Buy
189,510
+23,486
+14% +$607K 1.06% 22
2021
Q1 		$4.24M Buy
+166,024
New +$4.35M 1% 23

Other funds holding FTXH

DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

L.J. Altfest & Co's FTXH Position: Q2 2022 in Review

L.J. Altfest & Co sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2022, closing a stake of 9,444 shares — an estimated $251K sold.

L.J. Altfest & Co first reported a position in FTXH in Q1 2021 and held it in 5 quarters. The position peaked at $4.91M in Q2 2021. 20 funds tracked by Wall St. Rank hold FTXH as of Q2 2022.

  • L.J. Altfest & Co reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
  • L.J. Altfest & Co sold 9,444 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2022, an estimated $251K.
  • L.J. Altfest & Co first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2021 and held it in 5 quarters.
  • L.J. Altfest & Co's First Trust Nasdaq Pharmaceuticals ETF position peaked at $4.91M in Q2 2021.
  • 20 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2022.

Based on L.J. Altfest & Co's 13F filing for Q2 2022, filed 4 Aug 2022.